.jpg?Expires=1854835199&Signature=LYk1BJnLca2DfVpfcTLKfz69epx8W13ISegpEd-uU1bES5-Gxo3zII7FASxDKLx5dbvEVhap4D4fxoORM6ClpAepMroGMH7slhaHFUp~E5Qs0mOTtu9y1w2Pdr3YuCiehOjeQM3CDoVa1mFYuGupJI10XH7ApLjzL3NOqe4ZKzlIz~rsPnraeC1pMfvyDWdQk2SF1PpKIUJufLJlmqSWCxS6ren-H8X0qKYIsA3T8vWz0E4cF~iaKU-cieINJ6SrjuK0tmyAqfeKphGChxwY2iYH3sCfqvsv3Vd42qh4AYd7Hi4x92BpccxccYxcslopfCXlHAcmlBgd9QEFWJdpfw__&Key-Pair-Id=K901T7O9PELQE)
STEMON has developed Reprosome™, a next-generation exosome induced from induced pluripotent stem cells (iPSCs) using its proprietary UltraRepro® digital system and ENTR technology.
Reprosome™ contains a rich spectrum of regenerative and anti-inflammatory factors, produced without manual handling, ensuring uniformity, safety, and scalability. Induced in 3 minutes with Ultrarepro patented technology. Results have been published in ACS Nano, and the platform is IP-registered.
- Reprosome D – Skin Rich in skin growth factors (EGF) and anti-aging proteins including collagen, elastin, keratin, and PCNA. Promotes regeneration and firm, youthful skin.
- Reprosome A – Atopy & Inflammation Targets inflammation with factors that restore the skin barrier, reduce symptoms, and promote healing.
- Reprosome H – Hair Regeneration Contains follicle-inducing proteins like β-catenin, Shh, Krt25, Versican, Ptc1, and TCF3 for effective hair follicle activation.
- Telomere Reprosome – Anti-Aging Enriched with telomerase to lengthen telomeres, providing powerful cellular rejuvenation and anti-aging effects.
.jpg?Expires=1854835199&Signature=gN2-UjPKervVqfdLeF91Zu57yfz1d~R2QSakm9nKQx8iO3GGcSqIeERMLbPa~7fYsldJnkIJlEmLRVMOsxn4A2z~aD2ST-MJMcwmtLjqiB2QUqLF2fZE13mOKTLUIeLVE-Cimjzv7Ru3uN~gujTvyJB1sWzHQpCDvQv-sB-hkEMfvseUl8otv1Q1mm7OOfzQt0rY-AWIZCqhk7puKZN4Ayl114OiCzHPP1VXp5M95ZPyr-frFbFA3N-TtW5521XZOjiW05zpQKYN823mKSeTHfXwSqDD8fR71t-3Obgj8OfJEzmxNoDc9QpWl2YSCIKFJDn1QRAGPmtwOOC0L7jWZQ__&Key-Pair-Id=K901T7O9PELQE)
.jpg?Expires=1854835199&Signature=D~9DZuk5Z1FgtDauVYM7HRB90c6AFSJ7Vklpqx15De6ja5qaAl24SlvOZcQIZI7iwkWPXMCt1alj-0Cmkzo8SQreYEfMayBDPSChE21KmgVNoenUuoWwGvQiqge5IR6yNDutS8~S3DVX90SvNX-AGdgR2KMOi7V~Fr6JqwK9fTUmKJskpzFsIPh7BRiBj1j30p8OMp5rUBn8y5YfbDVUx8cdeFvVp0ICKl2h0CLjzsbrrGjGtooiEVePvpxXgV-l7ttoCWMG66R0bREcv14EsbjglqqmzYJRCwywyufg8aTxvPK7XsyEZ6VvQeV3jiuZc3D6GYKetuX8ohmahY6bQg__&Key-Pair-Id=K901T7O9PELQE)
.jpg?Expires=1854835199&Signature=Yg45AJX5-llVzjbtFw8SjnyV0qEYhdBR4-e6M7mQSz3FeEdYE9GODmFjM4RBqeynpZW4KNmvSZdLjr1dZrv2A8cbfxE3CUhzqck6RPV9yPkeqtejXL7-OCuetS9EgwefSffC4gwPmNq4hlKGSJV~7U3KUQSc-FRYIF~ZmFad9JKZbfNQeZsI73n5NQuhsImxpEhGUHDoeXlzrjlWirTBxPpybPwBZXZ2VFPzXRmQovEVOWeoq7-4S8KIXih1~eU3mMAVYCOoTECjRXTTor5hk3C8EyxOqyio9KeF2sZgQyacddZxS2FSQldk1Zi4v5~Jtt5j1Fyx9kYE1toD792vuA__&Key-Pair-Id=K901T7O9PELQE)
.jpg?Expires=1854835199&Signature=l8Imw9MDsJd~hTMitU8HgfYzLQQdBMU8W2xxBtvQRQQON1ur4hScwwVu9VvCV8E~xHhdkUg~XbsrhPUkHHbJBpDiA4usLpCS-jbMi4bmkY4ODLljK0Yc3s36czYTbOcKyeABmjkPxEUFu8iWeGgGjruNaPAwT2QwPc7Zg3PfGS5mGxZR9yAIjO6gw6pWO0684v6PEFU2SyCHBTk4301QC3g3S5Wdo~NFp9-uRMHJ5XeNqUovHQbIjLvu--S3t1chCUIbcxwZ~JQv2xiJfVWz5angRu0wz7EV7lus1bT1~hKU2kZmMCh2-EOB3aAS-9Js6~BHH7cCS~dJe7CFYL~Wwg__&Key-Pair-Id=K901T7O9PELQE)
